Case Study Leveraging the value of existing clinical trial data for oncology pipeline enhancement Posted on August 13, 2020 Situation A mid-size global pharma company operates with the business model of licensing in new molecules from biotech and academic world, developing in research organization from non- clinical up to clinical phase 2. • Emerging data strategy: the company’s ambition is to develop a robust pipeline with multiple Phase 1 and 2 programs in parallel, which required an overall automation and digitalization program for the company and more specifically for managing clinical R&D processes. • Managing a network of collaborators: Working with many external partners and CRO’s worldwide means that clinical data sets are generated by a variety of CRO’s using different

Join for free to read